Dacomitinib

Drug ingredient

CAS 1110813-31-4

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 1110813-31-4
US productionNot reported
Import value, 2024$7.6B
Top sourceIreland 61%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 293359 · basket

These shares come from HS customs code 293359, which covers 295 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries
IE 61%IrelandCH 30%SwitzerlandGB 2%United KingdomCN 2%ChinaIN 1%India
3 FDA-registered drug labelers
MSN Laboratories Private Limited
Pfizer Laboratories Div Pfizer Inc
U.S. Pharmaceuticals

Why It Matters

Sectors
Health
Downstream Uses

Appears in 1 drug and cosmetic product listings (FDA).

  • •Vizimpro
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS1110813-31-4
PubChem CID11511120
DTXSIDDTXSID50149493
FormulaC24H25ClFN5O2
Mol. Weight469.9 g/mol
SMILESCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4

Data Sources

Brief citations

Dacomitinib (CAS 1110813-31-4) https://chemicalindependence.com/chemical/1110813-31-4/ PubChem: 11511120. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/11511120 FDA National Drug Code directory: CAS 1110813-31-4. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/ US Census international trade: HS 293359 for CAS 1110813-31-4. Reporting year: 2024. https://usatrade.census.gov/